Noile-Immune Biotech (TSE:4893) Change In Inventory: 円0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4893 Noile-Immune Biotech Inc TSE:4893
46 GF Score
Price 円148.00
GF Value 円15.61
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Noile-Immune Biotech Change In Inventory?

Noile-Immune Biotech TSE:4893 +2.07% 46 Change In Inventory is 円0.00 Mil as of Jun. 2026. GuruFocus rates TSE:4893 with a GF Score™ of 46/100 and a GF Value™ of 円15.61 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Noile-Immune Biotech's change in inventory for the quarter that ended in Jun. 2026 was 円0.00 Mil. It means Noile-Immune Biotech's inventory stayed the same from Mar. 2026 to Jun. 2026 .

Noile-Immune Biotech's change in inventory for the fiscal year that ended in Dec. 2025 was 円6.42 Mil. It means Noile-Immune Biotech's inventory declined by 円6.42 Mil from Dec. 2024 to Dec. 2025 .

Noile-Immune Biotech's Total Inventories for the quarter that ended in Jun. 2026 was 円2.07 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year. Noile-Immune Biotech's Inventory Turnover for the quarter that ended in Jun. 2026 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Noile-Immune Biotech  (TSE:4893) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Noile-Immune Biotech's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=1.9075/0*365 / 4
=N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Noile-Immune Biotech's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=0 / 1.9075
=0.00

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Noile-Immune Biotech's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=1.9075 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Noile-Immune Biotech Change In Inventory Related Terms

Noile-Immune Biotech Change In Inventory Historical Data

* Premium members only.

The historical data trend for Noile-Immune Biotech's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Noile-Immune Biotech Change In Inventory Chart

Noile-Immune Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial 7.12 0.34 -16.98 12.33 6.42

Noile-Immune Biotech Quarterly Data
Dec20 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4893
46GF Score
Noile-Immune Biotech Inc TSE:4893
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Noile-Immune Biotech Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of 円0.00 Mil mean?
Noile-Immune Biotech (TSE:4893) has a Change In Inventory of 円0.00 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Noile-Immune Biotech and its competitors.
Is Noile-Immune Biotech's Change In Inventory too high?
Noile-Immune Biotech's current Change In Inventory is 円0.00 Mil. Overall, Noile-Immune Biotech has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Noile-Immune Biotech's Change In Inventory compare to VRTX and REGN?
Noile-Immune Biotech's Change In Inventory of 円0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Noile-Immune Biotech and its competitors. Noile-Immune Biotech's current Change In Inventory is 円0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Noile-Immune Biotech stock overvalued right now?
Based on GuruFocus' analysis, Noile-Immune Biotech (TSE:4893) is currently considered Significantly Overvalued. The stock's GF Value™ is 円15.61, compared to a current price of 円148.00 — trading 848.1% above its estimated fair value. The current Change In Inventory is 円0.00 Mil. Noile-Immune Biotech's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Noile-Immune Biotech (TSE:4893), the current Change In Inventory is 円0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Noile-Immune Biotech (TSE:4893) Overvalued in 2026?

Based on GuruFocus' analysis, Noile-Immune Biotech stock appears to be overvalued. The current stock price of 円148.00 is trading 848.1% above its estimated GF Value™ of 円15.61. GuruFocus considers Noile-Immune Biotech to be Significantly Overvalued.

Key valuation signals for TSE:4893:

  • Change In Inventory: 円0.00 Mil
  • GF Value™: 円15.61 vs. price of 円148.00 (848.1% above fair value)
  • GF Score™: 46/100 with 3 warning signs

No single metric tells the full story. See the TSE:4893 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Noile-Immune Biotech Business Description

Address 2-12-10 Shiba-Daimon, 5th Floor, T&G Hamamatsucho Building, Minato-ku, Yamaguchi, Tokyo, JPN, 105-0012
Noile-Immune Biotech Inc is engaged in the development of CAR-T cell therapy for solid cancers using its proprietary technology. The company's development pipeline and collaborative projects with other companies include different product candidates such as NIB102, NIB103, NIB104, ADAP01, AUTL01, etc. It operates in a single segment, the cancer immunotherapy drug discovery business.
46GF Score

Get the complete analysis for TSE:4893

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円148.00
Price
円15.61
GF Value